Table: Aska Pharmaceutical -Q1 group results

ASKA Pharmaceutical Holdings

07/08/2017 07:00

Aug 7 (Reuters)-  
             Aska Pharmaceutical Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 3 months ended      3 months ended       Year to  
                Jun 30, 2017        Jun 30, 2016     Mar 31, 2018  
                   LATEST             YEAR-AGO          LATEST     
                   RESULTS             RESULTS         FORECAST    
  Sales             12.81               11.99            50.00     
                 (+6.9 pct)          (+11.8 pct)      (+3.0 pct)   
  Operating          1.08              462 mln            2.00     
                (+132.8 pct)         (+98.5 pct)      (+11.5 pct)  
  Recurring          1.17              594 mln            2.10     
                 (+97.1 pct)         (+62.1 pct)      (+4.9 pct)   
  Net                1.04              526 mln            1.80     
                 (+98.3 pct)        (+181.1 pct)      (-38.9 pct)  
  EPS             37.10 yen           18.84 yen        64.39 yen   
  Ann Div                             14.00 yen        14.00 yen   
  -Q2 div                             7.00 yen         7.00 yen    
  -Q4 div                             7.00 yen         7.00 yen    
   
  NOTE - Aska Pharmaceutical Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4514.T  
  ((Tokyo Headline News Desk +813 6441 1812))